SE0201669D0 - New formulation and use thereof - Google Patents

New formulation and use thereof

Info

Publication number
SE0201669D0
SE0201669D0 SE0201669A SE0201669A SE0201669D0 SE 0201669 D0 SE0201669 D0 SE 0201669D0 SE 0201669 A SE0201669 A SE 0201669A SE 0201669 A SE0201669 A SE 0201669A SE 0201669 D0 SE0201669 D0 SE 0201669D0
Authority
SE
Sweden
Prior art keywords
formulation
administration
nicotine
lungs
essentially
Prior art date
Application number
SE0201669A
Other languages
English (en)
Swedish (sv)
Inventor
Mark P Warchol
Folke Moren
Kristina Thyresson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0201669A priority Critical patent/SE0201669D0/xx
Publication of SE0201669D0 publication Critical patent/SE0201669D0/xx
Priority to TW092114309A priority patent/TW200407142A/zh
Priority to CNB038128098A priority patent/CN100500148C/zh
Priority to RU2004139067/15A priority patent/RU2283111C2/ru
Priority to PCT/SE2003/000890 priority patent/WO2003101454A1/en
Priority to BR0311451-1A priority patent/BR0311451A/pt
Priority to DE60329592T priority patent/DE60329592D1/de
Priority to AU2003243074A priority patent/AU2003243074B2/en
Priority to CA2487699A priority patent/CA2487699C/en
Priority to MXPA04012041A priority patent/MXPA04012041A/es
Priority to EP03756140A priority patent/EP1509227B9/de
Priority to JP2004508811A priority patent/JP4745658B2/ja
Priority to NZ536863A priority patent/NZ536863A/en
Priority to AT03756140T priority patent/ATE444753T1/de
Priority to ES03756140T priority patent/ES2332405T3/es
Priority to DK03756140.4T priority patent/DK1509227T3/da
Priority to US10/453,808 priority patent/US7767698B2/en
Priority to ARP030101967A priority patent/AR039947A1/es
Priority to IL16519504A priority patent/IL165195A0/xx
Priority to ZA200409793A priority patent/ZA200409793B/en
Priority to US12/818,616 priority patent/US8642627B2/en
Priority to JP2010208203A priority patent/JP5430525B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE0201669A 2002-06-03 2002-06-03 New formulation and use thereof SE0201669D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof
TW092114309A TW200407142A (en) 2002-06-03 2003-05-27 New formulation and use thereof
DK03756140.4T DK1509227T3 (da) 2002-06-03 2003-05-30 En bufferet, flydende nikotinsammensætning til pulmonal indgivelse
EP03756140A EP1509227B9 (de) 2002-06-03 2003-05-30 Gepufferte flüssige nikotinzusammensetzung zur pulmonalen verabreichung
JP2004508811A JP4745658B2 (ja) 2002-06-03 2003-05-30 肺投与のための緩衝化液状ニコチン組成物
PCT/SE2003/000890 WO2003101454A1 (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
BR0311451-1A BR0311451A (pt) 2002-06-03 2003-05-30 Composição tamponada de nicotina lìquida para administração pulmonar
DE60329592T DE60329592D1 (de) 2002-06-03 2003-05-30 Gepufferte flüssige nikotinzusammensetzung zur pulmonalen verabreichung
AU2003243074A AU2003243074B2 (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
CA2487699A CA2487699C (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
MXPA04012041A MXPA04012041A (es) 2002-06-03 2003-05-30 Una composicion liquida y regulada de nicotina para administracion pulmonar.
CNB038128098A CN100500148C (zh) 2002-06-03 2003-05-30 用于肺部施用的缓冲液体烟碱组合物
RU2004139067/15A RU2283111C2 (ru) 2002-06-03 2003-05-30 Забуференная жидкая никотиновая композиция для легочного введения
NZ536863A NZ536863A (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition comprising a nicotine salt
AT03756140T ATE444753T1 (de) 2002-06-03 2003-05-30 Gepufferte flüssige nikotinzusammensetzung zur pulmonalen verabreichung
ES03756140T ES2332405T3 (es) 2002-06-03 2003-05-30 Una composicion de nicotina liquida tamponada para administracion pulmonar.
ARP030101967A AR039947A1 (es) 2002-06-03 2003-06-02 Formulacion farmaceutica que comprende nicotina
US10/453,808 US7767698B2 (en) 2002-06-03 2003-06-02 Formulation and use thereof
IL16519504A IL165195A0 (en) 2002-06-03 2004-11-14 A buffered, liquid nicotine composition for pulmonary administration
ZA200409793A ZA200409793B (en) 2002-06-03 2004-12-02 A buffered, liquid nicotine composition for pulmonary administration
US12/818,616 US8642627B2 (en) 2002-06-03 2010-06-18 Formulation and use thereof
JP2010208203A JP5430525B2 (ja) 2002-06-03 2010-09-16 肺投与のための緩衝化液状ニコチン組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof

Publications (1)

Publication Number Publication Date
SE0201669D0 true SE0201669D0 (sv) 2002-06-03

Family

ID=20288046

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof

Country Status (19)

Country Link
EP (1) EP1509227B9 (de)
JP (2) JP4745658B2 (de)
CN (1) CN100500148C (de)
AR (1) AR039947A1 (de)
AT (1) ATE444753T1 (de)
AU (1) AU2003243074B2 (de)
BR (1) BR0311451A (de)
CA (1) CA2487699C (de)
DE (1) DE60329592D1 (de)
DK (1) DK1509227T3 (de)
ES (1) ES2332405T3 (de)
IL (1) IL165195A0 (de)
MX (1) MXPA04012041A (de)
NZ (1) NZ536863A (de)
RU (1) RU2283111C2 (de)
SE (1) SE0201669D0 (de)
TW (1) TW200407142A (de)
WO (1) WO2003101454A1 (de)
ZA (1) ZA200409793B (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
ES2285233T3 (es) 2002-12-20 2007-11-16 Niconovum Ab Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable.
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
BR122018075478B8 (pt) 2004-06-24 2023-10-31 Vertex Pharma moduladores de transportadores de cassete de ligação de atp
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
HUE049976T2 (hu) 2005-12-28 2020-11-30 Vertex Pharma N-[2,4-bisz(1,1-dimetil-etil)-5-hidroxi-fenil]-1,4-dihidro-4-oxo-kinolin-3-karboxamid amorf alakjának gyógyászati kompozíciói
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
NZ600865A (en) * 2007-09-14 2014-01-31 Vertex Pharma Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN201379072Y (zh) 2009-02-11 2010-01-13 韩力 一种改进的雾化电子烟
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
CN102612361B (zh) * 2009-09-16 2014-11-05 菲利普莫里斯生产公司 传送药物的改良装置和方法
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
CA2824970C (en) 2011-02-11 2016-05-03 Batmark Limited Inhaler component
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
MX356624B (es) 2011-03-09 2018-06-06 Chong Corp Sistema de entrega de medicamento.
RU2595971C2 (ru) 2011-09-06 2016-08-27 Бритиш Америкэн Тобэкко (Инвестментс) Лимитед Нагревание курительного материала
EP3892125A3 (de) 2011-09-06 2022-01-05 Nicoventures Trading Limited Erwärmung eines rauchmaterials
AT511344B1 (de) 2011-10-21 2012-11-15 Helmut Dr Buchberger Inhalatorkomponente
US9907748B2 (en) * 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CN109966264A (zh) 2012-02-27 2019-07-05 沃泰克斯药物股份有限公司 药物组合物及其施用
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2504076A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB201215282D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd An inhaler
GB201215273D0 (en) * 2012-08-28 2012-10-10 Kind Consumer Ltd Nicotine composition
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
GB2513639A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513637A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
CA3208137A1 (en) * 2013-05-06 2014-11-13 Juul Labs, Inc. Nicotine salt formulations for aerosol devices and methods thereof
US11202470B2 (en) 2013-05-22 2021-12-21 Njoy, Inc. Compositions, devices, and methods for nicotine aerosol delivery
GB2514893B (en) 2013-06-04 2017-12-06 Nicoventures Holdings Ltd Container
US10251422B2 (en) 2013-07-22 2019-04-09 Altria Client Services Llc Electronic smoking article
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
CN110664012A (zh) 2013-12-23 2020-01-10 尤尔实验室有限公司 蒸发装置系统和方法
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP3148982A1 (de) * 2014-05-27 2017-04-05 R. J. Reynolds Tobacco Company Nikotinsalze, co-kristalle und salz-co-kristallkomplexe
GB2528673B (en) 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) * 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
KR102574658B1 (ko) 2014-12-05 2023-09-05 쥴 랩스, 인크. 교정된 투여량 제어
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201505597D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Article for use with apparatus for heating smokable material
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
CN114656446A (zh) * 2015-11-25 2022-06-24 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
US9867397B2 (en) 2016-01-11 2018-01-16 Patrick Beymer Nicotine delivery system
UA125687C2 (uk) 2016-02-11 2022-05-18 Джуул Лебз, Інк. Заповнювальний картридж випарного пристрою та способи його заповнення
SG10202108578XA (en) 2016-02-11 2021-09-29 Juul Labs Inc Securely attaching cartridges for vaporizer devices
EP3423058A4 (de) * 2016-02-29 2019-10-30 Nicogen Ltd. Nikotinformulierung und aerosole
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
KR20210009450A (ko) 2016-04-27 2021-01-26 니코벤처스 트레이딩 리미티드 전자 에어로졸 제공 시스템 및 전자 에어로졸 제공 시스템을 위한 증기화기
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
KR20200037220A (ko) * 2017-06-26 2020-04-08 누드 니코틴 인코포레이티드 니코틴 염 및 이의 제조 및 사용 방법
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
EP3574902A1 (de) * 2018-06-01 2019-12-04 Yatzz Limited Nikotinformulierung und modus der abgabe
GB201817864D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
CN113924004B (zh) 2019-06-07 2023-11-03 菲利普莫里斯生产公司 烟碱袋组合物
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
KR20220141284A (ko) 2019-12-15 2022-10-19 샤힌 이노베이션즈 홀딩 리미티드 초음파 미스트 흡입장치
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US20240148053A9 (en) 2019-12-15 2024-05-09 Shaheen Innovations Holding Limited Hookah device
KR102704091B1 (ko) 2019-12-15 2024-09-09 샤힌 이노베이션즈 홀딩 리미티드 미스트 흡입장치
EP3856304B1 (de) 2019-12-15 2023-11-08 Shaheen Innovations Holding Limited Ultraschall-nebelinhalator
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
EP3855949A4 (de) 2019-12-15 2021-08-04 Shaheen Innovations Holding Limited Ultraschall-nebelinhalator
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray

Also Published As

Publication number Publication date
AU2003243074A1 (en) 2003-12-19
MXPA04012041A (es) 2005-08-16
RU2004139067A (ru) 2005-08-10
JP2010280721A (ja) 2010-12-16
IL165195A0 (en) 2005-12-18
EP1509227B1 (de) 2009-10-07
RU2283111C2 (ru) 2006-09-10
NZ536863A (en) 2007-05-31
DK1509227T3 (da) 2010-02-01
ZA200409793B (en) 2006-08-30
CN100500148C (zh) 2009-06-17
ATE444753T1 (de) 2009-10-15
BR0311451A (pt) 2005-03-15
EP1509227A1 (de) 2005-03-02
JP2005533770A (ja) 2005-11-10
JP5430525B2 (ja) 2014-03-05
TW200407142A (en) 2004-05-16
DE60329592D1 (de) 2009-11-19
JP4745658B2 (ja) 2011-08-10
CA2487699C (en) 2012-04-17
WO2003101454A1 (en) 2003-12-11
AR039947A1 (es) 2005-03-09
ES2332405T3 (es) 2010-02-04
CA2487699A1 (en) 2003-12-11
CN1658876A (zh) 2005-08-24
EP1509227B9 (de) 2010-05-19
AU2003243074B2 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
SE0201669D0 (sv) New formulation and use thereof
SE0104388D0 (sv) New formulation and use and manufacture thereof
BRPI0515932A (pt) composições e métodos para distribuição intranasal, bucal, sublingual e pulmonar de vareniclina
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
DE50102490D1 (de) Verwendung von substituierten imidazo [1,2-a]pyridin-, -pyrimidin- und -pyrazin-3-yl-amin-derivaten zur herstellung von medikamenten zur nos-inhibierung
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
RS20090105A (en) Medicament compositions based on tiotropium salts and on salmetrol salts
HK1098960A1 (en) Method and composition for treating rhinitis
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
GB0323684D0 (en) Improvements in or relating to organic compounds
UY27759A1 (es) Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
DK1343472T3 (da) Thixotropisk næsespray
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
MY135460A (en) Method of stimulating hair growth using benzopyrans
CY1109215T1 (el) Συστημα χορηγησης οπιοειδους
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
BR0316123A (pt) Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico
ATE340576T1 (de) Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
BRPI0418582A (pt) sistema de administração de opióides
KR20060115092A (ko) 니코틴을 함유하는 구강청정제